Validation of 3D-DXA-derived proximal femur measurements against QCT across international clinical cohorts
Bone · 2026-10 · 211 · 117988
DOI: 10.1016/j.bone.2026.117988 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Bone, 2026-10. Verfasst von Marta I Bracco und 6 weiteren Autor:innen. Beteiligte Einrichtung: 3D-Shaper Medical, Barcelona, Spain. Electronic address: marta.bracco@3d-shaper.com. Hauptthemen laut MEDLINE: Femur, Absorptiometry, Photon, Tomography, X-Ray Computed, Imaging, Three-Dimensional. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Three-dimensional dual-energy X-ray absorptiometry (3D-DXA) reconstructs proximal femur models from standard DXA scans to estimate cortical and trabecular bone parameters. The aim of this study was to evaluate 3D-DXA against quantitative computed tomography (QCT) across independent international cohorts. The study included 531 subjects from four cohorts: an adult population from Spain, a postmenopausal female population from the United States, an osteoarthritis population and a young population, both from Japan. Subjects underwent both 3D-DXA and QCT imaging. Accuracy was assessed using linear regression and Bland-Altman analysis to evaluate systematic and random errors. 3D-DXA parameters strongly correlated with QCT across all datasets, with correlation coefficients between 0.82 and 0.97. Random errors were consistent across cohorts and ranged between 16.55 and 19.91 mg/cm3 for integral volumetric bone mineral density (vBMD), between 13.52 and 18.47 mg/cm3 for trabecular vBMD, and between 9.13 and 11.37 mg/cm2 for cortical surface bone mineral density (sBMD). Systematic errors ranged between -14.84 and 4.50 mg/cm3 for integral vBMD, between -8.31 and 14.41 mg/cm3 for trabecular vBMD, and between -5.58 and 3.21 mg/cm2 for cortical sBMD. The variations in systematic errors were likely attributable to differences in QCT acquisition protocols. Overall, these results demonstrate consistent agreement between 3D-DXA and QCT across sex, age, ethnicity, geographic regions, and clinical profiles. Taken together, these findings support the use of 3D-DXA as an accurate, non-invasive, and clinically accessible technology for advanced assessment of the cortical and trabecular compartments of the proximal femur.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 3D-Shaper Medical, Barcelona, Spain. Electronic address: marta.bracco@3d-shaper.com.
- University of California, San Francisco, CA, USA.
- Department of Nuclear Medicine, Kawasaki Medical School, 577, Matsushima, Kurashiki, Okayama, 701-0192, Japan.
- CETIR ASCIRES, Barcelona, Spain.
- Mineral Metabolism Unit, Grup Creu Groga, Mataró, Spain.
- 3D-Shaper Medical, Barcelona, Spain.
Zitieren
APA
Bracco, M. I., Black, D. M., Sone, T., Del Rio, L., de Gregorio, S., Malouf, J., & Humbert, L. (2026). Validation of 3D-DXA-derived proximal femur measurements against QCT across international clinical cohorts. Bone, 211, 117988. https://doi.org/10.1016/j.bone.2026.117988
Vancouver
Bracco MI, Black DM, Sone T, Del Rio L, de Gregorio S, Malouf J, et al. Validation of 3D-DXA-derived proximal femur measurements against QCT across international clinical cohorts. Bone. 2026;211:117988. doi:10.1016/j.bone.2026.117988
BibTeX
@article{Bracco2026,
author = {Bracco, Marta I and Black, Dennis M and Sone, Teruki and Del Rio, Luis and de Gregorio, Silvana and Malouf, Jorge and Humbert, Ludovic},
title = {Validation of 3D-DXA-derived proximal femur measurements against QCT across international clinical cohorts},
journal = {Bone},
year = {2026},
volume = {211},
pages = {117988},
doi = {10.1016/j.bone.2026.117988}
}
EUVIMED